SCNH2 is a novel apelinergic family member acting as a potent mitogenic and chemotactic factor for both endothelial and epithelial cells

Journals Menu

Follow SCIRP

ISSN Print: 2162-5816
ISSN Online: 2162-5824
www.scirp.org/journal/ojcd
E-mail: ojcd@scirp.org

Citations h5-index & Ranking*

"SCNH2 is a novel apelinergic family member acting as a potent mitogenic and chemotactic factor for both endothelial and epithelial cells"
written by Changge Fang, Ingalill Avis, Caterina Bianco, Natalie Held, Jennifer Morris, Kris Ylaya, Stephen M. Hewitt, Alfred C. Aplin, Roberto F. Nicosia, Laura A. Fung, John D. Lewis, William G. Stetler-Stevenson, David S. Salomon, Frank Cuttitta,
published by Open Journal of Clinical Diagnostics, Vol.3 No.2, 2013

has been cited by the following article(s):

[1]	Amidation-Modified Apelin-13 Regulates PPARγ and Perilipin to Inhibit Adipogenic Differentiation and Promote Lipolysis
	2021

[2]	Regulation of apelin-13 on Bcl-2 and caspase-3 and its effects on adipocyte apoptosis
	… -Based Complementary and …, 2021

[3]	Apelinergic system and its role in the development of resistance to antiangiogenic therapy in cancer treatment
	2020

[4]	Amidation
	2014

[5]	Apelin/APJ 系统与肿瘤的相关性研究进展
	实用医学杂志, 2014

[1]	Amidation-Modified Apelin-13 Regulates PPARγ and Perilipin to Inhibit Adipogenic Differentiation and Promote Lipolysis Bioinorganic Chemistry and Applications, 2021 DOI:10.1155/2021/3594630

[2]	Regulation of Apelin-13 on Bcl-2 and Caspase-3 and Its Effects on Adipocyte Apoptosis Evidence-Based Complementary and Alternative Medicine, 2021 DOI:10.1155/2021/1687919

[3]	Reference Module in Biomedical Sciences 2014 DOI:10.1016/B978-0-12-801238-3.04040-X

Follow SCIRP